HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John Digiovanni Selected Research

Insulin Resistance

2/2006Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John Digiovanni Research Topics

Disease

10Neoplasms (Cancer)
10/2013 - 02/2006
7Carcinogenesis
12/2012 - 02/2006
3Inflammation (Inflammations)
05/2013 - 11/2012
2Psoriasis (Pustulosis Palmaris et Plantaris)
05/2013 - 01/2012
2Breast Neoplasms (Breast Cancer)
12/2012 - 04/2004
1Condylomata Acuminata (Genital Wart)
10/2013
1Basal Cell Carcinoma (Rodent Ulcer)
10/2013
1Skin Neoplasms (Skin Cancer)
10/2013
1Actinic Keratosis
10/2013
1Arthritis (Polyarthritis)
05/2013
1Obesity
11/2012
1Adenocarcinoma
01/2012
1Wounds and Injuries (Trauma)
12/2010
1Infections
12/2010
1Squamous Cell Carcinoma of Head and Neck
09/2009
1Mouth Neoplasms (Oral Cancer)
09/2009
1Insulin Resistance
02/2006
1Carcinoma (Carcinomatosis)
08/2005
1Infertility (Sterility)
04/2004

Drug/Important Bio-Agent (IBA)

4Insulin-Like Growth Factor I (IGF-1)IBA
12/2012 - 02/2006
3Proteins (Proteins, Gene)FDA Link
11/2012 - 05/2008
2Interleukin-12 (IL 12)IBA
10/2013 - 05/2013
2Toll-Like Receptors (Toll-Like Receptor)IBA
10/2013 - 12/2010
2CytokinesIBA
05/2013 - 11/2012
2Insulin (Novolin)FDA Link
12/2012 - 11/2012
2GemcitabineFDA Link
08/2012 - 01/2012
2ErbB Receptors (EGF Receptor)IBA
01/2012 - 08/2005
2Phorbol EstersIBA
10/2009 - 12/2007
29,10-Dimethyl-1,2-benzanthraceneIBA
10/2009 - 05/2008
1Imiquimod (Aldara)FDA LinkGeneric
10/2013
1Interleukin-12 Subunit p35IBA
10/2013
1Interleukin-23 Subunit p19IBA
10/2013
1Interleukin-17 (Interleukin 17)IBA
10/2013
1VEL-0230IBA
05/2013
1Interleukin-23 (Interleukin 23)IBA
05/2013
1Cathepsin KIBA
05/2013
1Prostaglandins EIBA
12/2012
1LeptinIBA
11/2012
1SteroidsIBA
11/2012
1Hormones (Hormone)IBA
11/2012
1AdiponectinIBA
11/2012
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
08/2012
1Small Interfering RNA (siRNA)IBA
08/2012
1PolyethyleneimineIBA
08/2012
1DeoxycytidineIBA
08/2012
1Epidermal Growth Factor (EGF)IBA
01/2012
1LigandsIBA
01/2012
1indirubinIBA
01/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2011
1Biological ProductsIBA
04/2011
1Interferon Type IIBA
12/2010
1Nucleic AcidsIBA
12/2010
1Peptides (Polypeptides)IBA
12/2010
1CathelicidinsIBA
12/2010
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
04/2010
1AntibodiesIBA
10/2009
1Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2009
1Codon (Codons)IBA
10/2009
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2009
1Biomarkers (Surrogate Marker)IBA
09/2009
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2007
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
02/2006
1ThiazolidinedionesIBA
02/2006
1Phosphotransferases (Kinase)IBA
02/2006
1Rosiglitazone (Avandia)FDA Link
02/2006
1Troglitazone (Rezulin)FDA Link
02/2006
1Hypoglycemic Agents (Hypoglycemics)IBA
02/2006
1Gefitinib (Iressa)FDA Link
08/2005
1Tyrosine Kinase InhibitorsIBA
08/2005
1Estrogens (Estrogen)FDA Link
04/2004
18-Hydroxy-2'-DeoxyguanosineIBA
04/2004
1DNA (Deoxyribonucleic Acid)IBA
04/2004

Therapy/Procedure

2Diet Therapy (Therapy, Diet)
11/2012 - 05/2008
1Tertiary Prevention
11/2012
1Therapeutics
11/2012
1Oral Administration
02/2006